Cargando…
Fucoxanthin inhibits tumour‐related lymphangiogenesis and growth of breast cancer
Tumour lymphangiogenesis plays an important role in promoting the growth and lymphatic metastasis of tumours. The process is associated with cell proliferation, migration and tube‐like structure formation in lymphatic endothelial cells (LEC), but no antilymphangiogenic agent is currently used in cli...
Autores principales: | Wang, Jia, Ma, Yanhong, Yang, Jingshi, Jin, Lu, Gao, Zixiang, Xue, Lingyun, Hou, Lin, Sui, Linlin, Liu, Jing, Zou, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378177/ https://www.ncbi.nlm.nih.gov/pubmed/30648805 http://dx.doi.org/10.1111/jcmm.14151 |
Ejemplares similares
-
Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells
por: Yang, Yazong, et al.
Publicado: (2016) -
Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma
por: Teng, Hongming, et al.
Publicado: (2015) -
Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer
por: Barnes, N L P, et al.
Publicado: (2007) -
Targeting lymphangiogenesis to prevent tumour metastasis
por: Achen, M G, et al.
Publicado: (2006) -
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
por: Zimmermann, P, et al.
Publicado: (2009)